1. One of the goals of the Affordable Care Act (ACA) was to increase insurance coverage through a variety of policies: expansion of Medicaid, mandated coverage for dependent children up to age 26, and subsidies for those with relatively low income to purchase insurance. The ACA was largely successful in reducing the number of insured in the US. How would you explain this to affect the markets for pharmaceuticals and healthcare?